1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis
(
- Contribution to journal › Article
- 2020
-
Mark
A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy
(
- Contribution to journal › Article
- 2019
-
Mark
Intralymphatic Immunotherapy : Update and Unmet Needs
(
- Contribution to journal › Article
- 2018
-
Mark
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass : A randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Letter
- 2016
-
Mark
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Novel strategies for the treatment of grass pollen-induced allergic rhinitis
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis
(
- Contribution to journal › Article
- 2012
-
Mark
Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor.
(
- Contribution to journal › Article